What EAGLE PHARMACEUTICALS, INC.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Tarriff Scott | 10% owner | Feb 28 | Withheld — tax / exercise cost · F | −2,119 | $6.27 | −$13.3K | 460,621 |
| Tarriff Scott | 10% owner | Feb 27 | Withheld — tax / exercise cost · F | −3,154 | $6.44 | −$20.3K | 462,740 |
| Tarriff Scott | 10% owner | Feb 27 | Grant / award · A | +12,950 | — | — | 465,894 |
| Cahill Brian Joseph | CHIEF FINANCIAL OFFICER | Feb 27 | Withheld — tax / exercise cost · F | −1,589 | $6.44 | −$10.2K | 47,958 |
| Cahill Brian Joseph | CHIEF FINANCIAL OFFICER | Feb 27 | Grant / award · A | +3,800 | — | — | 49,547 |
| Cahill Brian Joseph | CHIEF FINANCIAL OFFICER | Feb 02 | Withheld — tax / exercise cost · F | −934 | $5.85 | −$5.46K | 45,747 |
| Tarriff Scott | 10% owner | Jan 05 | Withheld — tax / exercise cost · F | −4,322 | $5.13 | −$22.2K | 541,125 |
| Cahill Brian Joseph | Chief Financial Officer | Jan 05 | Withheld — tax / exercise cost · F | −735 | $5.13 | −$3.77K | 46,681 |
| Cahill Brian Joseph | Chief Financial Officer | Dec 18 | Withheld — tax / exercise cost · F | −452 | $4.76 | −$2.15K | 47,416 |
| Tarriff Scott | CEO | Nov 02 | Open-market sale · S | −10,694 | $13.87 | −$148K | 545,447 |
| Tarriff Scott | CEO | Nov 01 | Open-market sale · S | −10,925 | $13.82 | −$151K | 556,141 |
| Graves Michael | Director | Oct 27 | Exercise / conversion · M | +9,360 | $4.94 | +$46.2K | 10,360 |
| Tarriff Scott | CEO | Oct 03 | Open-market sale · S | −710 | $15.11 | −$10.7K | 567,066 |
| Tarriff Scott | CEO | Oct 03 | Open-market sale · S | −10,024 | $14.41 | −$144K | 567,776 |
| Tarriff Scott | CEO | Oct 02 | Open-market sale · S | −9,511 | $15.23 | −$145K | 577,800 |
| Tarriff Scott | CEO | May 16 | Open-market sale · S | −15,000 | $19.98 | −$300K | 587,311 |
| Tarriff Scott | CEO | May 15 | Open-market sale · S | −200 | $21.52 | −$4.3K | 1,594,934 |
| Tarriff Scott | CEO | May 15 | Open-market sale · S | −14,800 | $21.06 | −$312K | 1,595,134 |
| Tarriff Scott | CEO | May 12 | Open-market sale · S | −11,869 | $20.42 | −$242K | 1,609,934 |
| Tarriff Scott | CEO | May 12 | Open-market sale · S | −3,131 | $19.69 | −$61.6K | 1,621,803 |
Loading...
